CAR 세포치료 시장은 2024-2029년간 35억 5,730만 달러 확대되고, 예측 기간 동안 17.3%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. 세계의 CAR 세포치료(CAR Cell Therapy) 시장에 대해 조사 분석했으며, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더에 대한 벤더 분석 등의 정보를 전해드립니다.
현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. CAR 세포치료에 대한 인식 증가, 혈액암 유병률 증가, 혈액 악성종양 발병률 증가가 시장을 주도하고 있습니다.
| 시장 범위 |
| 기준 연도 |
2025년 |
| 종료 연도 |
2029년 |
| 예측 기간 |
2025-2029년 |
| 성장 모멘텀 |
가속 |
| 전년 대비(2025년) |
14.3% |
| CAGR |
17.3% |
| 증분 금액 |
35억 5,730만 달러 |
이 보고서는 향후 몇 년간 CAR 세포치료 시장의 성장을 견인할 주요 요인 중 하나로 자동차 T세포치료제 관련 제품 승인 및 임상시험 건수 증가를 꼽고 있습니다. 또한, 자동차 T세포 치료제의 설계를 재구성하기 위한 연구개발에 대한 투자 증가, 공동연구 및 파트너십 증가가 시장의 큰 수요로 이어질 것입니다.
목차
제1장 주요 요약
제2장 Technavio 분석
- 가격, 수명주기, 고객 구입 바스켓, 채택 비율, 구입 기준 분석
- 인풋의 중요성과 차별화 요인
- 혼란 요인
- 성장 촉진요인과 과제의 영향
제3장 시장 구도
제4장 시장 규모
- 시장의 정의
- 시장 부문 분석
- 시장 규모(2024년)
- 시장 전망(2024-2029년)
제5장 시장 규모 실적
- 세계의 CAR 세포치료 시장(2019-2023년)
- 최종사용자별 부문 분석(2019-2023년)
- 유형별 부문 분석(2019-2023년)
- 지역별 부문 분석(2019-2023년)
- 국가별 부문 분석(2019-2023년)
제6장 정성 분석
제7장 Five Forces 분석
- Five Forces 요약
- 바이어의 교섭력
- 공급 기업의 교섭력
- 신규 진출업체의 위협
- 대체품의 위협
- 경쟁 위협
- 시장 현황
제8장 시장 세분화 : 최종사용자별
- 시장 부문
- 비교 : 최종사용자별
- 병원 : 시장 규모와 예측(2024-2029년)
- 암 치료센터 : 시장 규모와 예측(2024-2029년)
- 시장 기회 : 최종사용자별
제9장 시장 세분화 : 유형별
- 시장 부문
- 비교 : 유형별
- CD19 : 시장 규모와 예측(2024-2029년)
- CD22 : 시장 규모와 예측(2024-2029년)
- BCMA : 시장 규모와 예측(2024-2029년)
- 기타 : 시장 규모와 예측(2024-2029년)
- 시장 기회 : 유형별
제10장 고객 상황
제11장 지역별 상황
- 지역별 세분화
- 비교 : 지역별
- 북미 : 시장 규모와 예측(2024-2029년)
- 유럽 : 시장 규모와 예측(2024-2029년)
- 아시아 : 시장 규모와 예측(2024-2029년)
- 기타 : 시장 규모와 예측(2024-2029년)
- 미국 : 시장 규모와 예측(2024-2029년)
- 영국 : 시장 규모와 예측(2024-2029년)
- 캐나다 : 시장 규모와 예측(2024-2029년)
- 중국 : 시장 규모와 예측(2024-2029년)
- 일본 : 시장 규모와 예측(2024-2029년)
- 독일 : 시장 규모와 예측(2024-2029년)
- 프랑스 : 시장 규모와 예측(2024-2029년)
- 인도 : 시장 규모와 예측(2024-2029년)
- 이탈리아 : 시장 규모와 예측(2024-2029년)
- 한국 : 시장 규모와 예측(2024-2029년)
- 지역 상황에 의한 시장 기회
제12장 성장 촉진요인, 과제, 기회 및 성장 억제요인
- 시장 성장 촉진요인
- 시장이 해결해야 할 과제
- 성장 촉진요인과 과제의 영향
- 시장 기회와 성장 억제요인
제13장 경쟁 구도
제14장 경쟁 분석
- 기업 개요
- 기업 순위 지수
- 기업의 시장 포지셔닝
- ACROBIOSYSTEMS INC.
- Allogene Therapeutics Inc.
- Bristol Myers Squibb Co.
- Celyad Oncology SA
- Eli Lilly and Co.
- Fate Therapeutics Inc.
- Fortress BIoTech Inc.
- Gilead Sciences Inc.
- GSK Plc
- Johnson and Johnson Inc.
- Miltenyi BIoTec B.V. and Co. KG
- Noile Immune BIoTech Inc.
- Novartis AG
- Pfizer Inc.
- Sorrento Therapeutics Inc.
제15장 부록
LSH
The car t-cell therapy market is forecasted to grow by $ 3557.3 mn during 2024-2029, accelerating at a CAGR of 17.3% during the forecast period. The report on the car t-cell therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing awareness regarding car t-cell therapy, increasing prevalence of blood cancer, and increasing incidence of hematological malignancies.
| Market Scope |
|---|
| Base Year | 2025 |
| End Year | 2029 |
| Series Year | 2025-2029 |
| Growth Momentum | Accelerate |
| YOY 2025 | 14.3% |
| CAGR | 17.3% |
| Incremental Value | $3557.3 mn |
Technavio's car t-cell therapy market is segmented as below:
By End-user
- Hospitals
- Cancer treatment centers
By Type
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the rising number of product approvals and clinical trials related to car t- cell therapy as one of the prime reasons driving the car t-cell therapy market growth during the next few years. Also, growing investments in research and development to remodel design of car-t therapy and growing number of collaborations and partnerships will lead to sizable demand in the market.
The report on the car t-cell therapy market covers the following areas:
- Car T-Cell Therapy Market sizing
- Car T-Cell Therapy Market forecast
- Car T-Cell Therapy Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading car t-cell therapy market vendors that include ACROBIOSYSTEMS INC., Allogene Therapeutics Inc., Bristol Myers Squibb Co., Celyad Oncology SA, Eli Lilly and Co., Fate Therapeutics Inc., Fortress Biotech Inc., Gilead Sciences Inc., GSK Plc, Johnson and Johnson Inc., Les Laboratoires Servier, Merck KGaA, Miltenyi Biotec B.V. and Co. KG, Noile Immune Biotech Inc., Novartis AG, Pfizer Inc., Sangamo Therapeutics Inc, and Sorrento Therapeutics Inc.. Also, the car t-cell therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5.1 Global CAR T-Cell Therapy Market 2019 - 2023
- Historic Market Size - Data Table on Global CAR T-Cell Therapy Market 2019 - 2023 ($ million)
- 5.2 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
- 5.3 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ million)
- 5.4 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- 5.5 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on the global CAR T-cell therapy market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by End-user
- 8.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
- 8.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- 8.3 Hospitals - Market size and forecast 2024-2029
- Chart on Hospitals - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
- Chart on Hospitals - Year-over-year growth 2024-2029 (%)
- Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
- 8.4 Cancer treatment centers - Market size and forecast 2024-2029
- Chart on Cancer treatment centers - Market size and forecast 2024-2029 ($ million)
- Data Table on Cancer treatment centers - Market size and forecast 2024-2029 ($ million)
- Chart on Cancer treatment centers - Year-over-year growth 2024-2029 (%)
- Data Table on Cancer treatment centers - Year-over-year growth 2024-2029 (%)
- 8.5 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
9 Market Segmentation by Type
- 9.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
- 9.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 9.3 CD19 - Market size and forecast 2024-2029
- Chart on CD19 - Market size and forecast 2024-2029 ($ million)
- Data Table on CD19 - Market size and forecast 2024-2029 ($ million)
- Chart on CD19 - Year-over-year growth 2024-2029 (%)
- Data Table on CD19 - Year-over-year growth 2024-2029 (%)
- 9.4 CD22 - Market size and forecast 2024-2029
- Chart on CD22 - Market size and forecast 2024-2029 ($ million)
- Data Table on CD22 - Market size and forecast 2024-2029 ($ million)
- Chart on CD22 - Year-over-year growth 2024-2029 (%)
- Data Table on CD22 - Year-over-year growth 2024-2029 (%)
- 9.5 BCMA - Market size and forecast 2024-2029
- Chart on BCMA - Market size and forecast 2024-2029 ($ million)
- Data Table on BCMA - Market size and forecast 2024-2029 ($ million)
- Chart on BCMA - Year-over-year growth 2024-2029 (%)
- Data Table on BCMA - Year-over-year growth 2024-2029 (%)
- 9.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 9.7 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
10 Customer Landscape
- 10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
- 11.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
- 11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 11.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- 11.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- 11.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- 11.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- 11.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 11.8 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 11.9 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 11.10 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 11.11 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 11.12 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 11.13 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 11.14 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 11.15 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- 11.16 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- 11.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
12 Drivers, Challenges, and Opportunity/Restraints
- 12.1 Market drivers
- 12.2 Market challenges
- 12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 12.4 Market opportunities/restraints
13 Competitive Landscape
- 13.1 Overview
- 13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 13.3 Landscape disruption
- Overview on factors of disruption
- 13.4 Industry risks
- Impact of key risks on business
14 Competitive Analysis
- 14.1 Companies profiled
- 14.2 Company ranking index
- 14.3 Market positioning of companies
- Matrix on companies position and classification
- 14.4 ACROBIOSYSTEMS INC.
- ACROBIOSYSTEMS INC. - Overview
- ACROBIOSYSTEMS INC. - Product / Service
- ACROBIOSYSTEMS INC. - Key offerings
- SWOT
- 14.5 Allogene Therapeutics Inc.
- Allogene Therapeutics Inc. - Overview
- Allogene Therapeutics Inc. - Product / Service
- Allogene Therapeutics Inc. - Key offerings
- SWOT
- 14.6 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- SWOT
- 14.7 Celyad Oncology SA
- Celyad Oncology SA - Overview
- Celyad Oncology SA - Product / Service
- Celyad Oncology SA - Key offerings
- SWOT
- 14.8 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key offerings
- SWOT
- 14.9 Fate Therapeutics Inc.
- Fate Therapeutics Inc. - Overview
- Fate Therapeutics Inc. - Product / Service
- Fate Therapeutics Inc. - Key offerings
- SWOT
- 14.10 Fortress Biotech Inc.
- Fortress Biotech Inc. - Overview
- Fortress Biotech Inc. - Business segments
- Fortress Biotech Inc. - Key offerings
- Fortress Biotech Inc. - Segment focus
- SWOT
- 14.11 Gilead Sciences Inc.
- Gilead Sciences Inc. - Overview
- Gilead Sciences Inc. - Product / Service
- Gilead Sciences Inc. - Key news
- Gilead Sciences Inc. - Key offerings
- SWOT
- 14.12 GSK Plc
- GSK Plc - Overview
- GSK Plc - Business segments
- GSK Plc - Key news
- GSK Plc - Key offerings
- GSK Plc - Segment focus
- SWOT
- 14.13 Johnson and Johnson Inc.
- Johnson and Johnson Inc. - Overview
- Johnson and Johnson Inc. - Business segments
- Johnson and Johnson Inc. - Key news
- Johnson and Johnson Inc. - Key offerings
- Johnson and Johnson Inc. - Segment focus
- SWOT
- 14.14 Miltenyi Biotec B.V. and Co. KG
- Miltenyi Biotec B.V. and Co. KG - Overview
- Miltenyi Biotec B.V. and Co. KG - Product / Service
- Miltenyi Biotec B.V. and Co. KG - Key news
- Miltenyi Biotec B.V. and Co. KG - Key offerings
- SWOT
- 14.15 Noile Immune Biotech Inc.
- Noile Immune Biotech Inc. - Overview
- Noile Immune Biotech Inc. - Product / Service
- Noile Immune Biotech Inc. - Key offerings
- SWOT
- 14.16 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- 14.17 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
- 14.18 Sorrento Therapeutics Inc.
- Sorrento Therapeutics Inc. - Overview
- Sorrento Therapeutics Inc. - Business segments
- Sorrento Therapeutics Inc. - Key offerings
- Sorrento Therapeutics Inc. - Segment focus
- SWOT
15 Appendix
- 15.1 Scope of the report
- 15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 15.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 15.4 Research methodology
- 15.5 Data procurement
- 15.6 Data validation
- 15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 15.8 Data synthesis
- 15.9 360 degree market analysis
- 360 degree market analysis
- 15.10 List of abbreviations
